These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1857872)

  • 1. Prevention of infections in granulocytopenic patients by fluorinated quinolones.
    Rozenberg-Arska M; Dekker AW; Verhoef J
    Recent Results Cancer Res; 1991; 121():337-46. PubMed ID: 1857872
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of infections in granulocytopenic patients by fluorinated quinolones.
    Rozenberg-Arska M; Dekker AW; Verhoef J
    Rev Infect Dis; 1989; 11 Suppl 5():S1231-6. PubMed ID: 2672251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of quinolones in the prevention of gram-negative bacteremia in neutropenic cancer patients and in the treatment of enteric infections.
    Bow EJ; Louie TJ
    Clin Invest Med; 1989 Feb; 12(1):61-8. PubMed ID: 2646056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of infections in granulocytopenic and immunocompromised cancer patients.
    Klastersky J
    Kansenshogaku Zasshi; 1988 Mar; 62 Suppl():25-34. PubMed ID: 3138351
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of quinolones as therapy in granulocytopenic cancer patients. Comparison with other antimicrobials.
    Krcméry V
    Drugs; 1995; 49 Suppl 2():139-43. PubMed ID: 8549284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of fever in granulocytopenic children with cancer.
    Katz JA; Mustafa MM
    Pediatr Infect Dis J; 1993 Apr; 12(4):330-7. PubMed ID: 8483628
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of bacterial and fungal infections in neutropenic patients with malignant hematologic diseases].
    Candoni A; Russo D; Salmaso F
    Clin Ter; 1997; 148(1-2):23-8. PubMed ID: 9377834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of infection in granulocytopenic patients.
    Young LS
    Haematol Blood Transfus; 1985; 29():119-22. PubMed ID: 4029726
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of antimicrobial synergism in infected granulocytopenic patients.
    Standiford HC; Johnson DE; Schimpff SC
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1007-10. PubMed ID: 6540682
    [No Abstract]   [Full Text] [Related]  

  • 10. Human immunoglobulins in the prophylaxis of infections in granulocytopenic neoplastic patients.
    Casali A; Ameglio F; Verri C; Tropea F; Paoletti G; Gallo Curcio C
    J Chemother; 1989 Jul; 1(4 Suppl):1313-5. PubMed ID: 16312881
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis and management of perianal and perirectal infection in the granulocytopenic patient.
    Rolston KV; Bodey GP
    Curr Clin Top Infect Dis; 1993; 13():164-71. PubMed ID: 8397908
    [No Abstract]   [Full Text] [Related]  

  • 12. Perspectives and controversies in the prevention of infection in granulocytopenic patients.
    Klastersky J
    Eur J Clin Microbiol; 1983 Apr; 2(2):91-4. PubMed ID: 6861738
    [No Abstract]   [Full Text] [Related]  

  • 13. Empirical antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials.
    Klastersky J
    Recent Results Cancer Res; 1988; 108():53-60. PubMed ID: 3051212
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of infection in granulocytopenic patients.
    Klastersky J
    J Antimicrob Chemother; 1983 Aug; 12(2):102-4. PubMed ID: 6619051
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advances in the epidemiology of infection in the granulocytopenic patient (author's transl)].
    Garau Alemany J
    Sangre (Barc); 1979; 24(5B):836-44. PubMed ID: 524230
    [No Abstract]   [Full Text] [Related]  

  • 16. [Co-trimoxazole chemoprophylaxis in immunocompromised patients: analysis of the literature].
    Gava R; Carli M
    G Clin Med; 1989 Jan; 70(1):37-9, 42-6. PubMed ID: 2668092
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemoprophylaxis of bacterial infections in granulocytopenic cancer patients using norfloxacin.
    Casali A; Verri C; Paoletti G; Tropea F; Modugno G; Frasca AM; Ameglio F; Tonachella R; Gallo Curcio C
    Chemioterapia; 1988 Oct; 7(5):327-9. PubMed ID: 3066518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients.
    Henry SA
    Am J Med; 1984 Apr; 76(4):645-51. PubMed ID: 6369979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylaxis of infections in granulocytopenic patients (author's transl].
    Grañena A; Rozman C; Aranalde JM; Feliú E; García J; Marín P; Montserrat-Costa E; Ribas Mundo M; Matutes E
    Sangre (Barc); 1979; 24(5B):857-67. PubMed ID: 524232
    [No Abstract]   [Full Text] [Related]  

  • 20. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract.
    Sleijfer DT; Mulder NH; de Vries-Hospers HG; Fidler V; Nieweg HO; van der Waaij D; van Saene HK
    Eur J Cancer (1965); 1980 Jun; 16(6):859-69. PubMed ID: 6997054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.